Fiscal 2022 Results – MJ Shareholders https://mjshareholders.com The Ultimate Marijuana Business Directory Fri, 10 Mar 2023 20:14:14 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.4 Jones Soda Reports Fourth Quarter and Full Year 2022 Results https://mjshareholders.com/jones-soda-reports-fourth-quarter-and-full-year-2022-results/ Fri, 10 Mar 2023 20:14:14 +0000 https://cannabisfn.com/?p=2972826

Ryan Allway

March 10th, 2023

News, Top News


Tenth Consecutive Quarter and Second Consecutive Year of Year-Over-Year Revenue Growth

SEATTLE, March 09, 2023 (GLOBE NEWSWIRE) — Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), the original craft soda company known for its unconventional flavors and user-designed label artwork, announced its financial results for the fourth quarter and full year ended December 31, 2022.

Fourth Quarter 2022 Financial Summary vs. Year-Ago Quarter

  • Revenue increased 28% to $3.7 million compared to $2.9 million.
  • Gross profit as a percentage of revenue was 24.8% compared to 26.5%.
  • Net loss was $1.6 million, or $(0.02) per share, compared to a net loss of $1.3 million, or $(0.02) per share.
  • Adjusted EBITDA1 was $(1.3) million compared to $(1.2) million. Adjusted EBITDA included approximately $871,000 in expenses related to the development and marketing of the Company’s cannabis infused beverages and related products sold under the “Mary Jones” brand name.

Full Year 2022 Financial Summary vs. Prior Year

  • Revenue increased 29% to $19.1 million compared to $14.8 million.
  • Gross profit as a percentage of revenue was 26.9% compared to 29.7%.
  • Net loss was $6.4 million or $(0.07) per share, compared to a net loss of $1.8 million, or $(0.03) per share.
  • Adjusted EBITDA1 was $(4.6) million compared to $(1.3) million. Adjusted EBITDA included approximately $3.6 million in expenses related to the development and marketing of the Company’s cannabis infused beverages and related products sold under the “Mary Jones” brand name.

Management Commentary

“We delivered our 10th consecutive quarter of year-over-year revenue growth as we completed the second year of our three-year turnaround strategy,” said Mark Murray, President and CEO of Jones Soda. “2022 was another notable year in which we made our successful entry into the cannabis market with our Mary Jones brand and continued market share gains in our core soda business with the addition of outstanding new partners across all of our distribution channels. Despite facing challenges posed by inflationary pressures, we stayed laser-focused on expanding our points of distribution, optimizing cost management, and strategically allocating our trade and marketing dollars. We believe this disciplined approach has enabled us to capitalize on growth opportunities despite volatility in the broader consumer market.

“At Jones Soda, we recognize the significance of innovation and new product developments that drive continued interest in our products from our loyal Jones Soda community. We brought back our Turkey and Gravy flavor over the holidays as part of our special release program and its return was met with even greater success than the year prior, delivering nearly seven times the volume it achieved in 2021. Coupled with our social media-based Turkey and Gravy Challenge, the special flavor earned the company over $5.0 million in combined ad value through organic publications and broadcasts. Furthering that momentum into the new year, we introduced our latest special release item with Key Lime 3.14 or ‘Pie’ flavor, and we also look forward to sharing the additional array of other exciting new offerings and special releases throughout 2023.

“We also look forward to potentially expanding the availability of our popular Mary Jones cannabis infused beverages and related products across several states. Recently, we announced the upcoming expansion into the state of Washington, where we will launch a full portfolio of products across beverages and edibles at both low and high dose options in the coming quarters. We believe our continued focus on seizing the opportunities within the cannabis market has been met with outstanding success. We are confident in this strategic initiative and remain committed to exploring additional product offerings to increase our presence in this rapidly growing industry.

“As we enter our last year of the initial three-year turnaround strategy, I’m proud to say that we are tracking ahead of where we thought we’d be by 2023. We continue to identify ways to enhance our product portfolio and expand into new territories, and we remain committed to satisfying the demands of our customer base and delivering the experiences they deserve. In addition, we intend to continue to develop our foodservice and fountain business, bringing the same spirit that the Jones Soda brand was founded upon into a channel that we believe has potential for growth. As we embark on the new year, we have complete confidence in our team’s ability to continue executing on our strategic objectives and delivering best-in-class product innovation to our customers.”

Fourth Quarter 2022 Financial Results

Revenue in the fourth quarter of 2022 increased 28% to $3.7 million compared to $2.9 million in the prior year period. The increase was primarily attributable to increased sales within our retail and alternative sales channels for our core bottled business, along with approximately $239,000 in revenue from the Company’s cannabis products that launched in 2022.

Gross profit as a percentage of revenue was 24.8% for the fourth quarter of 2022 compared to 26.5% in the year-ago period. The decrease was primarily driven by a one-time write-off related to discontinued programs, including the Mike Tyson and Costco Root Beer programs, and increased material costs, being partially offset by competitive price increases for our products.

Net loss for the fourth quarter of 2022 was $1.6 million, or $(0.02) per share, compared to a net loss of $1.3 million, or $(0.02) per share, in the fourth quarter of 2021. The increase in net loss was primarily attributable to the $871,000 of operating expenses and development costs related to the Company’s strategic entry into the cannabis sector during 2022 and the hiring of additional personnel to further develop the Company’s foodservice and fountain business.

Adjusted EBITDA1 in the fourth quarter of 2022 was $(1.3) million compared to $(1.2) million the prior year period. The decrease was primarily attributable to the aforementioned write-off related to discontinued programs and an increase in operating expenses.

Full Year 2022 Financial Results

Revenue in 2022 increased 29% to $19.1 million compared to $14.8 million in 2021. The increase was primarily attributable to the growth in the Company’s core bottled business through retail and alternative channels, along with generating approximately $353,000 in revenue from the Company’s cannabis products that launched in 2022.

Gross profit as a percentage of sales was 26.9% in 2022 compared to 29.7% in 2021. The decrease was primarily driven by increased material costs, being partially offset by competitive price increases for our products and the Company’s continued shift to a more favorable product mix.

Net loss was $6.4 million, or $(0.07) per share, in 2022 compared to a net loss of $1.8 million, or $(0.03) per share, in 2021. The increase in net loss was primarily attributable to the $3.6 million of expenses related to the Company’s strategic entry into the cannabis sector, additional personnel hires to support the Company’s foodservice and fountain business and a one-time $334,500 benefit recorded in the prior year period in connection with the forgiveness of a loan previously granted to the Company under the Payment Protection Program (PPP). In addition, as part of the Company’s strategic entry into the cannabis sector, the Company incurred an increase in stock compensation expenses primarily from the accelerated vesting of the Company’s outstanding options in connection with the closing of the plan of arrangement transaction with Pinestar Gold Inc.

Adjusted EBITDA1 in 2022 was $(4.6) million compared to $(1.3) million in 2021. The decrease in 2022 compared to 2021 was primarily attributable to the aforementioned increase in operating expenses.

The Company is expected to disclose complete figures for the balance sheet when it files its Form 10-K for the year ended December 31, 2022, in the coming weeks. The Company anticipates reporting cash and cash equivalents of approximately $8.0 million for the year ended December 31, 2022.

_____________________________
1 Adjusted EBITDA is defined as net income (loss) from operations before interest expense, interest income, taxes, depreciation, amortization and stock-based compensation and is a non-GAAP measure (reconciliation provided below).

Conference Call
Jones Soda will hold a conference call today at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2022.

Date: March 9, 2023
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Toll-free dial-in number: 1-877-407-0784
International dial-in number: 1-201-689-8560
Conference ID: 13735536

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.

The conference call will be broadcast live and available for replay here and via the investor relations section of the Company’s website at www.jonessoda.com.

A replay of the conference call will be available after 7:30 p.m. Eastern time on the same day through March 16, 2023.

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 13735536

Presentation of Non-GAAP Information
This press release contains disclosure of the Company’s Adjusted EBITDA which is not a United States Generally Accepted Accounting Principle (“GAAP”) financial measure. The difference between Adjusted EBITDA (a non-GAAP measure) and Net Loss (the most comparable GAAP financial measure) is the exclusion of interest expense and income, income tax expense, depreciation and amortization expense and stock-based compensation. We have included a reconciliation of Adjusted EBITDA to Net Loss under “Jones Soda Co. Non-GAAP Reconciliation” at the end of this press release. This non-GAAP measure should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to GAAP. Adjusted EBITDA has certain limitations in that it does not take into account the impact of certain expenses to our consolidated statements of operations. In addition, because Adjusted EBITDA may not be calculated identically by all companies, the presentation here may not be comparable to other similarly titled measures of other companies. We believe that Adjusted EBITDA provides useful information to investors about the Company’s results attributable to operations, in particular by eliminating the impact of non-cash charges related to stock-based compensation, amortization and depreciation that is consistent with the manner in which we evaluate the Company’s performance. These adjustments to the Company’s GAAP results are made with the intent of providing a more complete understanding of the Company’s underlying operational results and provide supplemental information regarding our current ability to generate cash flow. Adjusted EBITDA is not intended to be considered in isolation or as a replacement for, or superior to net loss as an indicator of the Company’s operating performance, or cash flow, as a measure of its liquidity. Adjusted EBITDA should be reviewed in conjunction with Net Loss as calculated in accordance with GAAP.

About Jones Soda Co.
Headquartered in Seattle, Washington, Jones Soda Co.® (CSE: JSDA, OTCQB: JSDA) markets and distributes premium beverages under the Jones® Soda and Lemoncocco® brands. A leader in the premium soda category, Jones Soda is made with pure cane sugar and other high-quality ingredients, and is known for packaging that incorporates ever-changing photos sent in from its consumers. Jones Soda’s diverse product line offers something for everyone – pure cane sugar soda, zero-calorie soda and Lemoncocco non-carbonated premium refreshment. Jones Soda is sold across North America in glass bottles, cans and on fountain through traditional beverage outlets, restaurants and alternative accounts. For more information, visit www.jonessoda.com or www.myjones.com or www.drinklemoncocco.com.

Forward-Looking Statements Disclosure
Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all passages containing words such as “will,” “aims,” “anticipates,” “becoming,” “believes,” “continue,” “estimates,” “expects,” “future,” “intends,” “plans,” “predicts,” “projects,” “targets,” or “upcoming.” Forward-looking statements also include any other passages that are primarily relevant to expected future events or that can only be evaluated by events that will occur in the future. Forward-looking statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated or implied in the forward-looking statements. Factors that could affect the Company’s actual results, including its financial condition and results of operations and its ability to continue as a going concern, include, among others: its ability to successfully execute on its growth strategies and operating plans for the future; the Company’s ability to continue to effectively utilize the proceeds from its financings completed in 2022; the Company’s ability to continue to develop and market THC/CBD-infused and/or cannabis-infused beverages and edibles, and comply with the laws and regulations governing cannabis, hemp or related products, and the timing and costs of the development of these new product lines; the Company’s ability to manage operating expenses and generate sufficient cash flow from operations; the Company’s ability to create and maintain brand name recognition and acceptance of its products; the Company’s ability to adapt and execute its marketing strategies; the Company’s ability to compete successfully against much larger, well-funded, established companies currently operating in the beverage industry generally and in the craft beverage segment specifically; the Company’s ability to respond to changes in the consumer beverage marketplace, including potential reduced consumer demand due to health concerns (including obesity) and legislative initiatives against sweetened beverages (including the imposition of taxes); its ability to develop and launch new products and to maintain brand image and product quality; the Company’s ability to maintain and expand distribution arrangements with distributors, independent accounts, retailers or national retail accounts; its ability to manage inventory levels and maintain relationships with manufacturers of its products; its ability to maintain a consistent and cost-effective supply of raw materials and flavors and manage the impact of the COVID-19 pandemic and other factors on its supply chain; its ability to attract, retain and motivate key personnel; its ability to protect its intellectual property; the impact of future litigation and the Company’s ability to comply with applicable regulations; its ability to maintain an effective information technology infrastructure, fluctuations in freight and fuel costs; the impact of currency rate fluctuations; its ability to access the capital markets for any future equity financing; the Company’s ability to maintain disclosure controls and procedures and internal control over financial reporting; dilutive and other adverse effects from future potential securities issuances; and any actual or perceived limitations by being traded on the OTCQB Marketplace. More information about factors that potentially could affect the Company’s operations or financial results is included in its most recent annual report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission (“SEC”) on March 14, 2022 and in the other reports filed with the SEC since that that date. Readers are cautioned not to place undue reliance upon these forward-looking statements that speak only as to the date of this release. Except as required by law, the Company undertakes no obligation to update any forward-looking or other statements in this press release, whether as a result of new information, future events or otherwise.

Company Contact:

Mark Murray
President and CEO
1-206-624-3357

Investor Relations Contact:

Cody Cree
Gateway Group
1-949-574-3860
JSDA@gatewayir.com

                       
JONES SODA CO.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
                       
  Three months ended December 31,   Twelve months ended December 31,
  2022
  2021
  2022
  2021
  (Unaudited)   (Unaudited)
   
Revenue $ 3,741     $ 2,912     $ 19,085     $ 14,792  
Cost of goods sold   2,813       2,139       13,942       10,394  
Gross profit   928       773       5,143       4,398  
Gross profit %   24.8 %     26.5 %     26.9 %     29.7 %
                       
Operating expenses:                      
Selling and marketing   1,238       899       4,965       3,003  
General and administrative   1,391       1,155       6,271       3,302  
    2,629       2,054       11,236       6,305  
Income (loss) from operations   (1,701 )     (1,281 )     (6,093 )     (1,907 )
Interest income   1       1       6       4  
Interest expense         (65 )     (377 )     (225 )
Other income, net   77       6       88       344  
Loss before income taxes   (1,623 )     (1,339 )     (6,376 )     (1,784 )
Income tax expense, net   (4 )     (3 )     (28 )     (27 )
Net loss $ (1,627 )   $ (1,342 )   $ (6,404 )   $ (1,811 )
                       
Net income (loss) per share – basic and diluted $ (0.02 )   $ (0.02 )   $ (0.07 )   $ (0.03 )
Weighted average common shares outstanding – basic and diluted   101,502,592       67,840,411       94,177,863       65,542,609  
                       
                       
JONES SODA CO.
NON-GAAP RECONCILIATION
(Unaudited, in thousands)
               
  Three months ended December 31,   Twelve months ended December 31,
  2022   2021   2022   2021
GAAP net income (loss) $ (1,627 )   $ (1,342 )   $ (6,404 )   $ (1,811 )
Stock based compensation   304       37       1,364       144  
Interest income   (1 )     (1 )     (6 )     (4 )
Interest expense         65       377       225  
Income tax expense, net   4       3       28       27  
Depreciation and Amortization   15       23       66       93  
Non-GAAP Adjusted EBITDA $ (1,305 )   $ (1,215 )   $ (4,575 )   $ (1,326 )
                       

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Grown Rogue Reports Fiscal 2022 Results, Revenue Growth of 89% and Positive Free Cash Flow https://mjshareholders.com/grown-rogue-reports-fiscal-2022-results-revenue-growth-of-89-and-positive-free-cash-flow/ Wed, 01 Mar 2023 19:04:35 +0000 https://cannabisfn.com/?p=2972740

Ryan Allway

March 1st, 2023

News, Top News


  • Revenue of $17.8M compared to $9.4M in 2021, an increase of 89%
  • Operating Cash Flow (OCF), before changes in working capital (WC), of $3.2M compared to $1.9M in 2021, an increase of 68%
  • Free Cash Flow1 (FCF) of $0.9M, after a $1.2M increase in WC and $1.1M in capital expenditures
  • The Company anticipates an increase in free cash flow in 2023 as a result of higher operating cash flow and lower capital expenditures compared to 2022
  • Subsequent to year-end, closed a $2.0M convertible debenture financing

MEDFORD, Ore.March 1, 2023 /CNW/ – Grown Rogue International Inc. (“Grown Rogue” or the “Company”) (CSE: GRIN) (OTC: GRUSF), a craft cannabis company operating in Oregon and Michigan, is pleased to report its audited 2022 results for the twelve months ended October 31, 2022. All financial information is provided in U.S. dollars unless otherwise indicated.

Fiscal 2022 Financial Summary ($USD Millions)

Fiscal 2022 Summary 2022 2021 +/- %
Revenue 17.8 9.4 +89 %
aEBITDA 5.1 2.3 +126 %
aEBITDA % 28.7 % 24.0 % +4.7 %
OCF (Before Changes in WC) 3.2 1.9 +68 %
OCF % 17.9 % 20.1 % (2.2 %)


Management Commentary

“I’m thrilled to report our fiscal 2022 results, which continue to show our ability to carefully and profitably scale our business, including being free cash flow positive and increasing revenue and aEBITDA by 89% and 126% respectively year-over-year,” said Obie Strickler, CEO of Grown Rogue. “Our relentless focus on delivering a high-quality craft product at the best price has led to customers responding by giving us more share in the markets we serve. I look forward to continuing this trend into our fiscal 2023, especially as Michigan’s capital improvements are now complete and we continue to optimize yields and institute a rigid focus on genetics.”

Continued Mr. Strickler: “Regarding our go-forward strategy and our capital allocation priorities, I want to note that many previously insulated markets are beginning to experience price normalization which we have long been familiar with in our home state of Oregon and now Michigan. But, even in markets where prices have fallen from their highs, they are still significantly above prevailing Oregon and Michigan pricing. This normalization has created distress among companies which cannot operate at prices we are comfortable with, and this distress has, in turn, lowered asset prices creating new and exciting opportunities for us. Our capital allocation is guided by our disciplined search for the most compelling ways of entering new markets where the ‘Grown Rogue Way’ will be successful. Our focus in 2023 on new market entry has been significantly bolstered by the $2M investment we recently closed, strengthening our balance sheet on great terms for the Company.”

Oregon Market Highlights ($USD Millions)

Oregon 2022 2021 +/- %
Revenue 8.9 5.2 +72 %
aEBITDA 2.6 1.7 +271 %
aEBITDA Margin % 29.0 % 32.7 % (3.8 %)
  • #1 Flower brand and #3 brand overall in 2022, according to LeafLink’s MarketScape data
  • #1 Flower brand for six consecutive quarters
  • Total harvested wet weights for the state of Oregon decreased 5% YoY for indoor, 18% YoY for mixed, and 17% YoY for outdoor, according to the Oregon Liquor and Cannabis Commission (OLCC)
  • Grown Rogue wet weight harvested for indoor and outdoor increased 45% and 88%, respectively, compared to 2021
  • Subsequent to year-end, Grown Rogue increased Oregon sungrown capacity with a lease option of 35 acres in Medford

Michigan Market Highlights ($USD Millions)

Michigan 2022 2021 +/- %
Revenue 8.9 3.9 +129 %
aEBITDA 3.9 2.2 +77 %
aEBITDA Margin % 43.8 % 56.4 % (12.6 %)
  • #10 wholesale flower brand in 2022, according to LeafLink’s MarketScape data
  • Added an additional $1.1M in fixed assets, including production from five additional flower rooms
  • More than doubled production in 2022 compared to 2021 and expect an additional 50% growth in 2023 reflecting the annualization of rooms built in 2022
  • Launched one gram pre-rolls (including nitrogen sealed varieties) in Q2 2022
  • Subsequent to year-end, Grown Rogue exercised its option to acquire its controlling interest in Golden Harvests, LLC

Michigan operations are through Golden Harvests, LLC.

Financial Statements and aEBITDA reconciliation

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION  October 31, 2022 October 31, 2021
$ $
ASSETS
Current assets
Cash and cash equivalents 1,582,384 1,114,033
Accounts receivable (Note 20) 1,643,959 739,248
Biological assets (Note 4) 1,199,519 1,188,552
Inventory (Note 5) 3,131,877 3,306,312
Prepaid expenses and other assets 352,274 357,541
Total current assets 7,910,013 6,705,686
Marketable securities (Note 6) 610,092
Other investments and purchase deposits (Note 8) 750,000
Property and equipment (Note 11) 7,734,901 5,742,584
Intangible assets and goodwill (Note 12) 725,668 399,338
TOTAL ASSETS 16,370,582 14,207,700
LIABILITIES
Current liabilities
Accounts payable and accrued liabilities 1,821,875 1,766,707
Current portion of lease liabilities (Note 10) 1,025,373 624,935
Current portion of long-term debt (Note 13) 1,769,600 843,900
Business acquisition consideration payable (Note 7) 360,000 358,537
Interest payable (Note 13) 13,750
Unearned revenue 28,024
Income tax 311,032 254,631
Total current liabilities 5,315,904 3,862,460
Accrued liabilities (Note 9) 123,413
Lease liabilities (Note 10) 1,275,756 1,735,503
Long-term debt (Note 13) 839,222 1,365,761
TOTAL LIABILITIES 7,430,882 7,087,137
EQUITY
Share capital (Note 14) 21,858,827 20,499,031
Shares issuable (Note 7) 35,806 74,338
Contributed surplus (Notes 15, 16) 6,505,092 6,407,935
Accumulated other comprehensive loss (109,613) (90,378)
Accumulated deficit (21,356,891) (21,804,349)
Equity attributable to shareholders 6,933,221 5,086,577
Non-controlling interests (Note 25) 2,006,479 2,033,986
TOTAL EQUITY 8,939,700 7,120,563
TOTAL LIABILITIES AND EQUITY 16,370,582 14,207,700
CONSOLIDATED STATEMENTS OF INCOME & LOSS Years ended October 31,
AND COMPREHENSIVE INCOME & LOSS 2022 2021
$ $
Revenue
Product sales 17,757,283 9,034,618
Service revenue 344,055
Total revenue 17,757,283 9,378,673
Cost of goods sold
Cost of finished cannabis inventory sold (9,227,439) (3,997,617)
Costs of service revenue (154,353)
Gross profit, excluding fair value items 8,529,844 5,226,703
Realized fair value amounts in inventory sold (3,685,338) (950,461)
Unrealized fair value gain on growth of biological assets 3,278,572 1,824,226
Gross profit 8,123,078 6,100,468
Expenses
Accretion expense 491,781 949,811
Amortization of intangible assets 4,997
Amortization of property and equipment 750,916 180,015
General and administrative 5,852,236 3,983,250
Share-based compensation 70,996 280,819
Total expenses 7,165,929 5,398,892
Income from operations 957,149 701,576
Other income and (expense)
Interest expense (402,239) (197,632)
Other expense (3,432) (17,072)
Gain on debt settlement 453,858 141,180
Loss on settlement of non-controlling interest (189,816)
Unrealized loss on marketable securities (333,777) (35,902)
Unrealized loss on derivative liability (1,258,996)
Loss on disposal of property and equipment (6,250) (7,542)
Gain (loss) from operations before income tax 665,309 (864,204)
Income tax (245,358) (150,543)
Net income (loss) 419,951 (1,014,747)
Other comprehensive income (items that may be subsequently

reclassified to profit & loss)

Currency translation loss (19,235) (78,181)
Total comprehensive income (loss) 400,716 (1,092,928)
Gain (loss) per share attributable to owners of the parent – basic & diluted 0.00 (0.02)
Weighted average shares outstanding – basic 169,193,812 135,231,802
Net income (loss) for the period attributable to:
Non-controlling interest (27,507) 1,395,558
Shareholders 447,458 (2,410,305)
Net income (loss) 419,951 (1,014,747)
Comprehensive income (loss) for the period attributable to:
Non-controlling interest (27,507) 1,395,558
Shareholders 428,223 (2,488,486)
Total comprehensive income (loss) 400,716 (1,092,928)
CONSOLIDATED STATEMENTS OF CASH FLOWS Year ended October 31,
2022 2021
$ $
Operating activities
Net income (loss) 419,951 (1,014,747)
Adjustments for non-cash items in net income (loss)
Amortization of property and equipment 750,916 180,015
Amortization of property and equipment include in costs of inventory sold 1,102,688 733,655
Amortization of intangible assets 4,997
Unrealized gain on changes in fair value of biological assets (3,278,572) (1,824,226)
Changes in fair value of inventory sold 3,685,338 950,461
Share-based compensation 21,264 170,136
Stock option expense 96,649 243,662
Accretion expense 491,781 949,811
Loss on disposal of property & equipment 6,250 7,542
Unrealized loss on marketable securities 333,777 35,902
Gain on debt settlement (455,674)
Loss on fair value of derivative liability 1,258,996
Loss on acquisition of non-controlling interest paid in shares 189,816
Effects of foreign exchange 918 7,233
3,175,286 1,893,253
Changes in non-cash working capital (Note 17) (1,171,111) (2,131,714)
Net cash provided by (used in) operating activities 2,004,175 (238,461)
Investing activities
Purchase of property and equipment and intangibles (1,111,283) (2,047,136)
Net cash acquired 76,128
Payments of acquisition payable (2,000) (6,000)
Other investments (750,000)
Net cash used in investing activities (1,113,283) (2,727,008)
Financing activities
Third party investment in subsidiary 475,000
Proceeds from long-term debt 100,000 1,125,000
Proceeds from private placement 1,300,000 1,225,000
Proceeds from brokered private placement 3,738,564
Payment of equity and debenture issuance costs (500,870)
Repayment of long-term debt (732,803) (507,715)
Repayment of convertible debentures (1,312,722)
Payments of lease principal (1,089,738) (380,543)
Net cash provided by (used in) financing activities (422,541) 3,861,714
Change in cash and cash equivalents 468,351 896,245
Cash and cash equivalents balance, beginning 1,114,033 217,788
Cash and cash equivalents balance, ending 1,582,384 1,114,033
SEGMENTED aEBITDA

YEAR ENDED OCTOBER 31, 2022

Oregon Michigan Corporate Consolidated
Sales revenues 8,852,104 8,905,179 17,757,283
Costs of goods sold, excluding fair value

(“FV“) adjustments

(5,762,802) (3,464,637) (9,227,439)
Gross profit before fair value adjustments 3,089,302 5,440,542 8,529,844
Net fair value adjustments (50,143) (356,623) (406,766)
Gross profit 3,039,159 5,083,919 8,123,078
Operating expenses:
General and administration 1,982,911 2,217,413 1,651,912 5,852,236
Depreciation and amortization 84,919 562,443 103,554 750,916
Share based compensation 70,996 70,996
Other income and expense:
Loss on sale of assets (6,250) (6,250)
Interest and accretion (293,103) (242,601) (358,316) (894,020)
Gain (loss) on debt settlement 6,020 (1,847) 449,685 453,858
Unrealized gain on marketable securities (333,777) (333,777)
Other income and expense 5,400 (8,832) (3,432)
Net income (loss) before tax 683,396 2,059,615 (2,077,702) 665,309
Tax 27,787 217,571 245,358
Net income after tax 655,609 1,842,044 (2,077,702) 419,951
Add back (deduct) from net income after tax:
Realized FV amounts included in inventory sold 1,388,657 2,296,681 3,685,338
Unrealized FV gain on growth of biological assets (1,338,514) (1,940,058) (3,278,572)
Amortization of property & equipment included

in cost of sales

756,795 345,893 1,102,688
Interest and interest accretion expense 293,103 242,601 358,316 894,020
Amortization of property and equipment 84,919 562,443 103,554 750,916
Share-based compensation 117,913 117,913
Unrealized loss on marketable securities 333,777 333,777
Income tax expense 27,787 217,571 245,358
EBITDA 1,868,356 3,567,175 (1,164,142) 4,271,389
Add back (deduct) from EBITDA:
Performance incentive bonus payment 179,685 179,685
Severance and inactive employee compensation 61,077 61,077
Business development incentive bonus 153,825 153,825
Gain on debt settlement for marketable securities (449,684) (449,684)
Compliance costs 98,139 98,139
Costs associated with acquisition of Golden Harvests 80,000 80,000
New production location startup costs 697,120 697,120
aEBITDA 2,565,476 3,900,685 (1,374,610) 5,091,551
aEBITDA margin % 29.0 % 43.8 % 28.7 %
NOTES:
1. The Company’s “Free cash flow” metric is defined by cash flow from operations minus capital expenditures.
2. The Company’s “aEBITDA,” or “Adjusted EBITDA,” is a non-IFRS measure used by management that does not have any prescribed meaning by IFRS and that may not be comparable to similar measures presented by other companies. The Company defines “EBITDA” as the Company’s net income or loss for a period, as reported, before interest, taxes, depreciation and amortization, and is further adjusted to remove transaction costs, stock-based compensation expense, accretion expense, gain (loss) on derecognition of derivative liabilities, the effects of fair-value accounting for biological assets and inventory, as well as other non-cash items and items not representative of operational performance as reported in net income (loss). Adjusted EBITDA is defined as EBITDA adjusted for the impact of various significant or unusual transactions. The Company believes that this is a useful metric to evaluate its operating performance.


NON-IFRS FINANCIAL MEASURES

EBITDA and aEBITDA are non-IFRS measures and do not have standardized definitions under IFRS. The Company has also provided unaudited pro-forma financial information, which assumes that closed and pending mergers and acquisitions in 2021 are included in the Company’s financial results as of the beginning of the quarterly and annual periods in 2021. The Company has provided the non-IFRS financial measures, which are not calculated or presented in accordance with IFRS, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with IFRS. These supplemental non-IFRS financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-IFRS financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-IFRS financial measures should not be considered superior to, as a substitute for or as an alternative to, and should only be considered in conjunction with, the IFRS financial measures presented herein. Accordingly, the following information provides reconciliations of the supplemental non-IFRS financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with IFRS.

About Grown Rogue

Grown Rogue International (CSE: GRIN | OTC: GRUSF) is a craft cannabis company focused on delighting customers with premium flower and flower-derived products at fair prices. Our roots are in Southern Oregon where we have demonstrated our capabilities in the highly competitive and discerning Oregon market and, more recently, we successfully expanded our platform to Michigan. We combine our passion for product and value with a disciplined approach to growth, prioritizing profitability and return on capital. Our strategy is to pursue capital efficient methods to expand into new markets, bringing our craft quality and value to more consumers. We also continue to make modest investments to improve our outdoor craft cultivation capabilities in preparation for eventual interstate commerce.

FORWARD-LOOKING STATEMENTS

This press release contains statements which constitute “forward–looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities. Forward– looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” or similar expressions and include information regarding: (i) statements regarding the future direction of the Company (ii) the ability of the Company to successfully achieve its business and financial objectives, (iii) plans for expansion of the Company and securing applicable regulatory approvals, and (iv) expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward–looking information is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections concerning the business of the Company’s future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward–looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those projected in the forward–looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and related costs, and other risks described in the Company’s public disclosure documents filed on Sedar.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward–looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward–looking information except as otherwise required by applicable law.

The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company’s business are disclosed in the Company’s Listing Statement filed on its issuer profile on SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

SOURCE Grown Rogue International Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>